Reduced state transition Viterbi differential detection of M-ary DPSK signals

1996 ◽  
Vol 32 (12) ◽  
pp. 1064 ◽  
Author(s):  
F. Adachi
Keyword(s):  
State Transition ◽  
Differential Detection ◽  
Reduced State

scholarly journals FINDING ATTRACTORS IN ASYNCHRONOUS BOOLEAN DYNAMICS

2011 ◽  
Vol 14 (03) ◽  
pp. 439-449 ◽  
Author(s):  
THOMAS SKODAWESSELY ◽  
KONSTANTIN KLEMM
Keyword(s):  
Fixed Points ◽  
State Transition ◽  
Boolean Networks ◽  
Computational Method ◽  
State Transitions ◽  
Transition Graph ◽  
Numerical Tests ◽  
State Transition Graph ◽  
Boolean Dynamics ◽  
Reduced State

We present a computational method for finding attractors (ergodic sets of states) of Boolean networks under asynchronous update. The approach is based on a systematic removal of state transitions to render the state transition graph acyclic. In this reduced state transition graph, all attractors are fixed points that can be enumerated with little effort in most instances. This attractor set is then extended to the attractor set of the original dynamics. Our numerical tests on standard Kauffman networks indicate that the method is efficient in the sense that the total number of state vectors visited grows moderately with the number of states contained in attractors.

X-RAY ABSORPTION SPECTROSCOPY STUDY OF Cu-BASED METHANOL CATALYSTS. 2. REDUCED STATE

1986 ◽  
Vol 47 (C8) ◽  
pp. C8-237-C8-242 ◽  
Author(s):  
B. S. CLAUSEN ◽  
B. LENGELER ◽  
B. S. RASMUSSEN ◽  
W. NIEMANN ◽  
H. TOPSØE
Keyword(s):  
Absorption Spectroscopy ◽  
Spectroscopy Study ◽  
X Ray ◽  
X Ray Absorption ◽  
Reduced State

Detection of Carriers in Glanzmann's Thrombasthenia

1983 ◽  
Vol 49 (03) ◽  
pp. 182-186
Author(s):  
G T E Zonneveld ◽  
E F van Leeuwen ◽  
A Sturk ◽  
J W ten Cate
Keyword(s):  
Bleeding Time ◽  
Periodic Acid ◽  
Type I ◽  
Clot Retraction ◽  
Periodic Acid Schiff ◽  
Glanzmann’S Thrombasthenia ◽  
Aggregation Response ◽  
Glanzmann's Thrombasthenia ◽  
Sds Page ◽  
Reduced State

SummaryQuantitative glycoprotein (GP) analysis of whole platelets or platelet membranes was performed by SDS-polyacrylamide gelelectrophoresis (SDS-PAGE) and periodic acid Schiff staining in the families of two unrelated Glanzmann’s thrombasthenia (GT) patients. Each family consisted of two symptom free parents, a symptom free daughter and a GT daughter. All symptom free members had a normal bleeding time, clot retraction and platelet aggregation response to adenosine 5’-diphosphate (ADP), collagen and adrenalin. Platelet Zw* antigen was normally expressed in these subjects. GT patiens, classified as a type I and II subject, showed reduced amounts of GP lib and of GP nia. Analysis of isolated membranes in the non-reduced state, however, showed that the amount of GP Ilia was also reduced in three of the four parents, whereas one parent (of the GT type I patient) and the two unaffected daughters had normal amounts of GP Ilia. Quantitative SDS-PAGE may therefore provide a method for the detection of asymptomatic carriers in GT type I and II.

Differential Detection of Single-Chain and Two-Chain Urokinase-Type Plasminogen Activator by a New Immunoadsorbent-Amidolytic Assay (IAA)

1986 ◽  
Vol 56 (03) ◽  
pp. 407-410 ◽  
Author(s):  
Angelo Corti ◽  
Maria Luisa Nolli ◽  
Giovanni Cassani
Keyword(s):  
Plasminogen Activator ◽  
Carcinoma Cell ◽  
Differential Detection ◽  
Single Chain ◽  
Response Curves ◽  
Type Plasminogen Activator ◽  
Urokinase Type Plasminogen Activator ◽  
Before And After ◽  
Culture Supernatants ◽  
Human Epidermoid Carcinoma

SummaryA new immunoadsorbent-amidolytic assay (IAA) for the specific differential detection of two-chain urokinase-type plasminogen activator (tcu-PA) and its single-chain precursor (scu-PA) in cell culture supernatants has been developed. The assay combines the selectivity of immunoassays with the specificity of enzyme activity assays exploiting both the antigenic and enzymatic properties of the two proteins. tcu-PA and scu-PA are selectively immunoadsorbed on the wells of a microtiterplate coated with the monoclonal antibody 5B4 and tested for enzymatic activity before and after activation by plasmin treatment. Both proteins are determined with similar efficiency since overlapping dose-response curves were obtained in the range between 12.5-200 ng/ml. The assay has been used to determine tcu-PA and scu-PA in A431 human epidermoid carcinoma cell supernatants. The analytical recoveries for tcu-PA and scu-PA added to A431 cell supernatants were 95.2% and 96.9% respectively. The intra- and inter-assay variations (CV) were 5.5% and 9.0% for tcu-PA and 9.7% and 9.8% for scu-PA respectively.

Sign in / Sign up

Export Citation Format

Share Document